title: Cervical cancer prevention - current perspectives.
abstract: This report addresses several areas including the progress made toward global implementation of currently licensed human papillomavirus (HPV) vaccines, and monitoring impact of HPV vaccination programs that can be implemented within developed and less-developed countries. For the sake of completeness, a short update on the evolution of HPV testing in primary screening programs at present and after HPV vaccine introduction has also been included.
authors: Institute of the Cervix, Paris, France. jmonsonego@wanadoo.fr
authors: J
authors: J
authors: Monsonego
mesh_terms: D005260:Female; D006176:Gynecology / Q000639:trends; D006801:Humans; D008403:Mass Screening / Q000379:methods; D053918:Papillomavirus Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D014611:Vaccination / Q000009:adverse effects / Q000379:methods; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis / Q000517:prevention & control*
chemical_list: D053918:Papillomavirus Vaccines